109 related articles for article (PubMed ID: 113355)
1. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--III. 2'-[82Br]-bromo-2'-deoxyuridine.
Lee YW; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):109-112. PubMed ID: 113355
[No Abstract] [Full Text] [Related]
2. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine.
Abrams DN; Knaus EE; Lentle BC; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):103-7. PubMed ID: 157998
[No Abstract] [Full Text] [Related]
3. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.
Abrams DN; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):97-101. PubMed ID: 478772
[No Abstract] [Full Text] [Related]
4. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VI. 1-(3'-[36Cl]-chloro-, 1-(3'-[82Br]-bromo- and 1-(3'-[123I]-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil.
Lee YW; Mercer JR; Wiebe LI; Knaus EE
Int J Appl Radiat Isot; 1984 Nov; 35(11):1057-61. PubMed ID: 6526522
[TBL] [Abstract][Full Text] [Related]
5. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil.
Lee YW; Abrams DN; Wiebe LI; Knaus EE
Int J Nucl Med Biol; 1984; 11(3-4):262-6. PubMed ID: 6549392
[No Abstract] [Full Text] [Related]
6. Radiolabelled pyrimidine nucleosides to monitor the expression of HSV-1 thymidine kinase in gene therapy.
Wiebe LI; Knaus EE; Morin KW
Nucleosides Nucleotides; 1999; 18(4-5):1065-6. PubMed ID: 10432739
[TBL] [Abstract][Full Text] [Related]
7. Loss of labelled DNA from rat brain following injections of precursors with high specific radioactivity. II. DNA labelled with 5-[131I]iodo-2'-deoxyuridine and 5-[82Br]bromo-2'-deoxyuridine.
Merits I; Cain JC
Biochim Biophys Acta; 1970; 209(2):327-38. PubMed ID: 5453521
[No Abstract] [Full Text] [Related]
8. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VII. [2-14C]-5-ethyl-1-(2'-deoxy-beta-D-ribofuranosyl)uracil.
Lee YW; Giziewicz JB; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1984 Nov; 35(11):1063-6. PubMed ID: 6335492
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of DNA synthesis and pyrimidine deoxyribonucleoside transport systems in mouse glioma and mouse neuroblastoma cells by inorganic mercury.
Nakada S; Imura N
Toxicol Appl Pharmacol; 1980 Mar; 53(1):24-8. PubMed ID: 7385234
[No Abstract] [Full Text] [Related]
10. Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracils.
Mercer JR; Xu LH; Knaus EE; Wiebe LI
J Med Chem; 1989 Jun; 32(6):1289-94. PubMed ID: 2524593
[TBL] [Abstract][Full Text] [Related]
11. Development and bioevaluation of (o)-82Br[77Br]-bromohippuran.
Van Wyk AJ; Bekker P; Niemann D; Roesch H; Fourie PJ; Haasbroek FJ; Venter SS
Int J Appl Radiat Isot; 1983 Jul; 34(7):1019-21. PubMed ID: 6618696
[No Abstract] [Full Text] [Related]
12. Pyrimidine metabolism in microplasmodia of Physarum polycephalum.
Fink K; Nygaard P
Eur J Biochem; 1978 Sep; 89(2):417-24. PubMed ID: 710400
[TBL] [Abstract][Full Text] [Related]
13. The disposition of the antitumor agent, sangivamycin, in mice.
Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
[No Abstract] [Full Text] [Related]
14. Synthesis of 2-deoxy-2-[82Br]bromo-D-mannose and related compounds and their biodistributions in mice.
Zhou YG; Shiue CY; Wolf AP; Arnett CD
Eur J Nucl Med; 1985; 11(6-7):252-6. PubMed ID: 4076231
[TBL] [Abstract][Full Text] [Related]
15. Salvage of circulating pyrimidine nucleosides in the rat.
Moyer JD; Oliver JT; Handschumacher RE
Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
Silagi S; Balint RF; Gauri KK
Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681
[No Abstract] [Full Text] [Related]
17. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.
Lee YW; Iwashina T; Gati WP; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1985 May; 36(5):395-8. PubMed ID: 4018900
[TBL] [Abstract][Full Text] [Related]
18. Studies on the abnormal excretion of pyrimidine nucleosides in the urine of Yoshida ascites sarcoma-bearing rats. Increased excretion of deoxycytidine, pseudouridine and cytidine.
Shimizu M; Fujimura S
Biochim Biophys Acta; 1978 Feb; 517(2):277-86. PubMed ID: 626740
[No Abstract] [Full Text] [Related]
19. Structural modifications at the 2'- and 3'-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter.
Gati WP; Misra HK; Knaus EE; Wiebe LI
Biochem Pharmacol; 1984 Nov; 33(21):3325-31. PubMed ID: 6497896
[TBL] [Abstract][Full Text] [Related]
20. Uphill transport of pyrimidine nucleosides in renal brush border vesicles.
Le Hir M; Dubach UC
Pflugers Arch; 1985 Jul; 404(3):238-43. PubMed ID: 4034370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
